- ¥366bn
- ¥217bn
- ¥2tn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.84 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -19.35% | ||
| Dividend Yield (f) | 2.8% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.88 | ||
| Price to Tang. Book | 0.91 | ||
| Price to Free Cashflow | 23.26 | ||
| Price to Sales | 0.14 | ||
| EV to EBITDA | 4.64 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.72% | ||
| Return on Equity | 9.23% | ||
| Operating Margin | 1.35% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 2,239,112 | 2,314,828 | 2,386,493 | 2,399,952 | 2,486,647 | 2,584,235 | 2,638,453 | 3.16% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +62.39 | +25.97 | +34.23 | +21.72 | +20.85 | -34.22 | -0.7 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SUZUKEN CO.,LTD. is a Japan-based company mainly engaged in the sale of pharmaceuticals and related products, the manufacture and sale of pharmaceuticals, medical devices and related products and other businesses. It operates through five business segments. Pharmaceutical Wholesaling segment engages in the sale of ethical pharmaceuticals, diagnostic agents, medical devices and medical materials. Healthcare Product Development segment engages in the research and development, manufacture and sale of ethical pharmaceuticals, diagnostic agents and medical devices and materials. Community Medical and Nursing Care Support segment provides services related to insurance pharmacies and nursing care. Specialty Pharmaceutical Distribution Entrusted segment provides support services to manufacturers of specialty pharmaceuticals. Medical Related Services segment provides manufacturer support services, including outsourced logistics for pharmaceutical manufacturers and digital healthcare services.
Directors
- Hiromi Miyata PRE (61)
- Shigeru Asano EVP (55)
- Hisashi Tamura SME (60)
- Akihiko Someya MEO (59)
- Hirofumi Tanaka MEO (58)
- Osamu Abe SEO
- Naoaki Kato SEO
- Takahiro Kuroyanagi SEO
- Tadashi Yamamoto SEO
- Masayuki Tanaka SEO
- Masanobu Nohara SEO
- Takashi Kamitani SEO
- Keiichi Yokoyama SEO
- Chie Takahashi EXO (54)
- Masahiro Hamanaka EXO
- Toyoaki Ohta EXO
- Yoshihiro Ohtsuka EXO
- Koji Sakashita EXO
- Asako Tomita EXO
- Yoshiki Bessho DRC (78)
- Toshiaki Iwatani IND (59)
- Takeshi Ogasawara IND (68)
- Shunichi Samura IND (75)
- Keisuke Ueda IND (78)
- Yasunori Usui IND (67)
- Last Annual
- March 31st, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- August 10th, 1946
- Public Since
- August 1st, 1994
- No. of Shareholders
- 8,439
- No. of Employees
- 12,717
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange
- Shares in Issue
- 135,275,690

- Address
- 8, Higashi Kataha-machi, Higashi-ku, NAGOYA-SHI, 461-8701
- Web
- https://www.suzuken.co.jp
- Phone
- +81 529612331
- Auditors
- Deloitte Touche Tohmatsu LLC
Latest News for 9987
Upcoming Events for 9987
Q2 2027 Suzuken Co Ltd Earnings Release
Q3 2027 Suzuken Co Ltd Earnings Release
Dividend For 9987.T - 30.0000 JPY
Similar to 9987
ASKA Pharmaceutical Holdings
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings
Tokyo Stock Exchange
CanBas
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
As of Today at 05:35 UTC, shares in Suzuken are trading at ¥2,703. This share price information is delayed by 15 minutes.
Shares in Suzuken last closed at ¥2,703 and the price had moved by -8.25% over the past 365 days. In terms of relative price strength the Suzuken share price has underperformed the Nikkei 225 Index by -32.19% over the past year.
The overall consensus recommendation for Suzuken is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Suzuken dividend yield is 1.85% based on the trailing twelve month period.
Last year, Suzuken paid a total dividend of ¥50, and it currently has a trailing dividend yield of 1.85%.Looking ahead, the next dividend pay date is 2026-12-10.
We do not have data on when Suzuken is to next pay dividends. The historic dividend yield on Suzuken shares is currently 1.85%.
To buy shares in Suzuken you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥2,703, shares in Suzuken had a market capitalisation of ¥366bn.
Here are the trading details for Suzuken:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 9987
Based on an overall assessment of its quality, value and momentum Suzuken is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Suzuken is ¥2,946. That is 9.02% above the last closing price of ¥2,703.
Analysts covering Suzuken currently have a consensus Earnings Per Share (EPS) forecast of ¥183 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Suzuken. Over the past six months, its share price has underperformed the Nikkei 225 Index by -18%.
As of the last closing price of ¥2,703, shares in Suzuken were trading -3.27% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Suzuken PE ratio based on its reported earnings over the past 12 months is 14.84. The shares last closed at ¥2,703.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Suzuken's management team is headed by:
- Hiromi Miyata - PRE
- Shigeru Asano - EVP
- Hisashi Tamura - SME
- Akihiko Someya - MEO
- Hirofumi Tanaka - MEO
- Osamu Abe - SEO
- Naoaki Kato - SEO
- Takahiro Kuroyanagi - SEO
- Tadashi Yamamoto - SEO
- Masayuki Tanaka - SEO
- Masanobu Nohara - SEO
- Takashi Kamitani - SEO
- Keiichi Yokoyama - SEO
- Chie Takahashi - EXO
- Masahiro Hamanaka - EXO
- Toyoaki Ohta - EXO
- Yoshihiro Ohtsuka - EXO
- Koji Sakashita - EXO
- Asako Tomita - EXO
- Yoshiki Bessho - DRC
- Toshiaki Iwatani - IND
- Takeshi Ogasawara - IND
- Shunichi Samura - IND
- Keisuke Ueda - IND
- Yasunori Usui - IND





